Yusuf A 1
,
Sarfati D 2
,
Booth CM 3
,
Pramesh CS 4
,
Lombe D 5
,
Aggarwal A 6
Show all authors
,
Bhoo-Pathy N 7
,
Tsunoda A 8
,
Vanderpuye V 9
,
Kutluk T 10
,
Sullivan A 11
,
Mukherji D 12
,
Mutebi M 13
,
van Hemelrijck M 14
,
Sullivan R 15
,
COVID-19 and Cancer Global Taskforce
Affiliations
- 1 Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan
- 2 National Director of Cancer Control, and Chief Executive Cancer Control Agency, Wellington, New Zealand
- 3 Queen's University Cancer Research Institute, Kingston, ON, Canada
- 4 Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
- 5 Cancer Diseases Hospital, Lusaka, Zambia
- 6 London School of Hygiene & Tropical Medicine, London, UK; Institute of Cancer Policy, School of Cancer & Pharmaceutical Sciences, King's College London & Guy's and St Thomas' NHS Trust, London, UK
- 7 Faculty of Medicine, University Malaya, Malaysia
- 8 Hospital Erasto Gaertner, PPGTS/Pontifícia Universidade Católica do Paraná, Curitiba, Brazil
- 9 National Center for Radiotherapy, Oncology and Nuclear Medicine, Korlebu Teaching Hospital, Accra, Ghana
- 10 Department of Pediatric Oncology, Hacettepe University Faculty of Medicine & Cancer Institute, Sıhhiye-Ankara, Turkey
- 11 School of Life Sciences, University of Warwick, Coventry, UK
- 12 Faculty of Medicine, American University of Beirut, Beirut, Lebanon
- 13 Breast Surgical Oncology, Aga Khan University, Nairobi, Kenya
- 14 Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK
- 15 Institute of Cancer Policy, School of Cancer & Pharmaceutical Sciences, King's College London & Guy's and St Thomas' NHS Trust, London, UK. Electronic address: richard.sullivan@kcl.ac.uk
PMID: 33930324
DOI: 10.1016/S1470-2045(21)00244-8
* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.